Indivior Pharmaceuticals, Inc. (INDV)
Market Closed
17 Jul, 20:00
$
40. 54
-0.05
-0.1232%
$
5.05B Market Cap
- P/E Ratio
- Div Yield
984,700 Volume
1.35 Eps
$ 40.59
Previous Close 
Want to track INDV and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Indivior Pharmaceuticals, Inc. (INDV) Statistics
Valuation metrics
Market Cap 5.05B
Enterprise value 5.39B
Trailing P/E (ttm) 20.17
Forward P/E 9.65
PEG ratio 0.02
Price/Sales (ttm) 3.92
Price/Book (mrq) -35.29
Enterprise Value/Revenue 4.18
Enterprise Value/EBITDA 15.32
Overview
Shares outstanding 122M
Float 103.78M
Shares short 12.82M
% Held by insiders 0.01%
% Held by institutions 1.05%
Average volume (10 days) 922.34K
Average volume (90 days) 2.18M
Price summary
52-Week low 15.48
52-Week high 42.81
Beta 1.2
50-Day moving average 39.81
200-Day moving average 34.22
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 29 Jul 2016
Ex-Dividend Date 16 Jun 2016
Last split factor 1:5
Last split Date 10 Oct 2022
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.19%
Operating margin 0.33%
Operational effectiveness
Return on assets 0.21%
Return on equity -1.42%
Income Statement
Revenue (ttm) 1.29B
Revenue per share (ttm) 10.3
Quarterly revenue growth (yoy) 0.19%
Gross profit (ttm) 1.1B
EBITDA 374M
Net income to common (ttm) 252M
Diluted EPS (ttm) 2
Quarterly earnings growth (yoy) 0.89%
Balance Sheet
Total cash (mrq) 175M
Total cash per share (mrq) 1.4
Total debt (mrq) 509M
Total Debt/Equity (mrq) -3.53
Current ratio (mrq) 0.86%
Book value per share (mrq) -1.15
Cash Flow
Cash flow statement -111M
Levered free cash flow (LFCF) 44.25M
